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damjan.glavac@mf.uni-lj.si (D. Glavacˇ), marko.hawlinPurpose of this study was to molecularly characterize a family in which two brothers (46 and 36 years)
presented with a combination of retinitis pigmentosa (RP) and severe sensorineural hearing loss while
father and sister (71 and 41 years) presented with isolated RP. Retinal phenotype was compared with
phenotype of 17 patients with Usher syndrome type 1. Ophthalmological examination included assess-
ment of Snellen visual acuity, color vision with Ishihara tables, Goldmann perimetry (targets II/1–4)
and microperimetry. Fundus autoﬂuorescence imaging and optical coherence tomography were per-
formed. Direct sequencing of all coding exons and ﬂanking intronic sequences of GJB2 (gap junction pro-
tein, beta 2) and PRPH2 (peripherin 2) genes was performed in younger brother. Other family members
were analyzed with sequencing (GJB2), high resolution melt analysis (GJB2) or restriction enzymes
(PRPH2). Brothers with hearing loss were found to carry a homozygous c.35delG mutation in GJB2, the
most common mutation associated with recessive hearing loss. All patients were found to carry a novel
heterozygous mutation c.389T > C (p.Leu130Pro) on PRPH2. Age of onset was higher in PRPH2 than USH1
patients, however with some overlap. Differentiation from retinal phenotype of USH1 could only be made
in the oldest patient, who retained good central visual function after more than three decades of disease.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Hereditary retinal disorders are an important cause of severe
visual impairment. Many of these patients have associated hand-
icaps, and it has been estimated that 10–30% of patients with
retinitis pigmentosa (RP) also have some form of hearing impair-
ment (Bayazit & Yilmaz, 2006; Keats, 2002). Usher syndrome is a
recessive disorder, characterized by RP and sensorineural hearing
loss, which accounts for more than 50% of all deaf–blind patients
(Vernon, 1969) or about 18% of pigmentary retinopathies
(Boughman, Vernon, & Shaver, 1983). Hearing loss can be severe
(USH1), moderate (USH2) or progressive (USH3). Nonsyndromicll rights reserved.
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a@gmail.com (M. Hawlina).autosomal recessive hearing loss is most commonly associated
with mutations in GJB2, encoding connexin 26 (Duman & Tekin,
2012). Nonsyndromic autosomal dominant retinitis pigmentosa
(adRP) is most often caused by mutations in RHO, PRPF31, RP1,
RDS or IMPDH1. Mutations in RDS/Peripherin (PRPH2) are respon-
sible for 6% of ADRP (Daiger, 2004). Purpose of this study was to
molecularly characterize a family in which two brothers pre-
sented with a combination of RP and severe sensorineural hearing
loss while father and sister presented with nonsyndromic RP.2. Materials and methods
2.1. Patients
This case study included four related patients with RP and/or
hearing loss. Two brothers (46 and 36 years) presented with a
combination of RP and profound sensorineural hearing loss. Father
and sister (71 and 41 years) presented with isolated RP. Diagnosis
of RP was based on nyctalopia, visual ﬁeld constriction, pigmentary
retinal changes and full-ﬁeld scotopic and photopic electroretinog-
raphy. Profound sensorineural hearing loss was previously con-
ﬁrmed by audiometry (hearing threshold level in the better ear
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Fig. 1. DNA analysis ﬁndings in the younger brother with combination of retinitis
pigmentosa and hearing loss. (A) Heterozygous T > C substitution at position 389 of
PRPH2, resulting in leucine to proline amino acid change at position 130 (reverse
strand is shown). (B) Homozygous deletion of G at position 35 of GJB2, resulting in
shift of reading frame. A = Adenine, C = Cytosine, G = Guanine, T = Thymine.
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Fig. 2. Family tree and clinical data. Microperimetry results are overlaid on top of FAF an
ISe and ELM loss. VA = visual acuity, ISH = Ishihara color vision test, OCT = optical coher
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conduction thresholds showing the same degree of hearing loss).
Retinal phenotype was compared with 17 USH1 patients, ages 7–
69 years. They all had combination of recessive RP and hearing
loss; 12 were genetically analyzed and conﬁrmed as Usher syn-
drome. Study was approved by Slovenian Ethics Committee for Re-
search in Medicine and all research procedures have been carried
out in accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involving hu-
mans. Informed consent was obtained from all subjects.
2.2. Ophthalmological examination
Ophthalmological examination included assessment of Snellen
visual acuity, color vision with Ishihara tables, and Goldmann
perimetry (targets II/1–4). Static microperimetry was performed
with the Nidek MP1 (Nidek Technologies, Padua, Italy) after pupil
dilation with topical 1% tropicamide. Fifty six stimuli in the central
20 of retina (program Humphrey10-216dB56s) were used. Stimuli
were the size of Goldmann III target (4 mm2), appeared for 200 ms
and their intensities changed in 4–2 strategy. Fundus autoﬂuores-
cence imaging of 30 ﬁeld of view and 8-mm Spectral-domain OCT
scan trough the fovea were performed simultaneously with a con-
focal scanning laser ophthalmoscope (OCT-SLO Spectralis, Heidel-
berg Retina Angiograph 2, Heidelberg Engineering, Dossenheim,
Germany) after pupil dilation with topical 1% tropicamide. Tempo-
ral horizontal radius of the hyperautoﬂuorescent ring (distance
from fovea to inner border) was measured on FAF image using
Spectralis software with micrometer caliper and rounded to
0.01 mm to compensate for measurement error. Conversion of
1 mm of retina to 3.5 of visual ﬁeld was used.
2.3. Molecular methods
Mutational analysis of GJB2 and PRPH2 genes was performed in
younger brother by direct sequencing of coding regions and ﬂank-
ing intronic sequences. ABI Prism 310 capillary sequencer (Applied
Biosystems, Foster City, CA, USA) was used for sequencing inRetinitis pigmentosa 
Sensorineural hearing loss
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d OCT images. Green lines represent site of OCT scan. Yellow lines represent site of
ence tomography, AF = fundus autoﬂuorescence, MP = microperimetry.
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Fig. 3. (A) Visual ﬁeld overlaid on fundus autoﬂuorescence in a patient with the shortest disease duration (1 year since onset of nyctalopia). Visual ﬁeld is reﬂected across the
horizontal line. Lines with increasing thickness represent Goldmann targets II/1–4. Dimmer targets (II/1–3) spatially correlate with hyperautoﬂuorescent ring while the
brightest (II/4) target is detected well outside the ring. Absolute scotoma correlates with hypoautoﬂuorescent patches on FAF. (B) Visual ﬁeld and ring size in association with
disease duration. Right eyes of the four patients are presented. Visual ﬁelds and inner ring radii are smaller in patients with longer disease duration. Goldmann II/1 target is
detected internally while II/2 target is detected externally from the inner ring border.
A. Fakin et al. / Vision Research 75 (2012) 71–76 73combination with BigDye Terminator v.1.1 chemistry (Applied
Biosystems, Foster City, CA, USA). GJB2 sequencing was performed
using two sets of primers (1F: GTGTTGTGTGCATTCGTCTTTT, 1R:
TCACTCTTTATCTCCCCCTTGA; 2F: ACGATCACTACTTCCCCATCTC,
2R: CTCATCCCTCTCATGCTGTCTA). PRPH2 sequencing wasperformed using three sets of primers (1F: TACAGCTTGGGCCA-
TCTGCACTTT, 1R: TTGTGCACCCGATGGAGAGGAAA; 2F: TATTCTA-
GGTTTCCAGAGGCAGGG, 2R: ACTGAAGGCTGTTTCCAAAGAGGG;
3F: AGGCTCCTGTGGTTTCCTAATGGT, 3R: ACTATTTCTCAGTGTTCG-
GGAGGG). Screening of other family members was performed with
74 A. Fakin et al. / Vision Research 75 (2012) 71–76high resolution melt analysis (GJB2) and with restriction enzymes,
where recognition site for AvaI was available (PRPH2). Results
obtained with high resolution melt analysis were additionally con-
ﬁrmed by direct sequencing.3. Results
3.1. Molecular results
Father and all three children were found to carry a heterozy-
gous mutation c.389T > C (p.Leu130Pro) on PRPH2 gene (Fig. 1A).
Brothers with hearing loss were also found to carry a homozygous
c.35delG mutation in GJB2 gene (Fig. 1B). This mutation was found
in heterozygous state in parents and was absent in sister.
3.2. Clinical data
Four patients presented with retinitis pigmentosa (Fig. 2). Age
of onset (nyctalopia) varied from 15–45 years (average 29 years).
Patients presented with typical ﬁndings like bone spicules in the
mid periphery, narrowed vessels, and optic disc pallor (not shown).Patients
USH1PRPH2
A
ge
 a
t d
is
ea
se
 o
ns
et
 (y
ea
rs
)
50
40
30
20
10
0
Disease duration (years)
6050403020100
Vi
su
al
 a
cu
ity
1,0
0,8
0,6
0,4
0,2
0,0
USH1
PRPH2
Patients
PRPH2: R2 Lin. = 1
USH1: R2 Lin. = 0.6 
A
B
Fig. 4. (A) Box plot graph showing ages at disease onset (nyctalopia) in PRPH2
(N = 4) and USH1 (N = 17) patients. Horizontal lines represent median values.
PRPH2 patients had signiﬁcantly later disease onset than USH1 patients however
with some overlap. (B) Visual acuity in association with disease duration in PRPH2
and USH1 patients. PRPH2 patients retained normal VA late in the disease whereas
signiﬁcant decline was seen in USH1 patients after 30 years of disease duration.All patients had normal visual acuity and only father, who had the
longest disease duration (41 years) had moderate loss of color vi-
sion (Ishihara 7/15 dex and 8/15 sin). Goldmann perimetry with
II/4 target showed constricted visual ﬁelds in three patients (8–
14, disease duration 10–41 years; not shown) and relatively pre-
served visual ﬁeld (60) in the older brother, with 1 year of disease
duration (Fig. 3A). II/1 and II/2 were constricted in all four patients
(3–9 and 5–12, respectively; Fig 2B). FAF revealed parafoveal
hyperautoﬂuorescent rings in all, with inner ring radii from 4 to
10 (Fig. 2). Visual ﬁelds and rings were smaller in patients with
longer disease duration (Fig. 3B.). Inner ring border spatially corre-
lated with inner segment ellipsoid (ISe) loss while outer ring bor-
der correlated with external limiting membrane (ELM) loss on
OCT (Fig. 2). Microperimetry showed loss of retinal sensitivity out-
side the rings (Fig. 2).3.3. Comparison of retinal phenotype between PRPH2 and USH1
patients
All patients had typical signs of RP, including of night vision loss
and constricted visual ﬁelds. USH1 patients had in average earlier
disease onset (nyctalopia) than PRPH2 patients (10 vs. 29 years,
respectively, Fig. 4A). Visual acuity was normal in all patients with
PRPH2, even in patients with more than 30 years since onset, while
USH1 retained good VA only to up to 30 years since onset (Fig. 4B).
All PRPH2 patients had relatively large (radius > 3) hyperautoﬂu-
orescent rings. Rings were seen in 8/11 (73%) of USH1 patients
with up to 30 years of disease duration and in 1/6 (17%) patients
with more than 30 years of disease duration. The latter ring was
smaller than 3. Other USH1 patients had central hyperautoﬂuores-
cence (foveal patch) or atrophy, associated with photoreceptor
degeneration in the foveal area. OCT in patients with rings showed
similar morphological changes in the retina. From the fovea to-
wards periphery, loss of ISe was seen, followed by ELM loss and
signiﬁcant thinning of outer nuclear (ONL) layer (Fig. 5).4. Discussion
Combination of RP and hearing loss in the two brothers was
found to be a result of mutations in two different genes. Hearing
loss was caused by homozygous mutation c.35delG in GJB2 gene,
which is the most common mutation associated with hereditary
hearing loss (Hochman et al., 2010) Retinitis pigmentosa was prob-
ably associated with a missense mutation c.389T > C (p.Leu130Pro)
in PRPH2 gene. This novel mutation results in amino acid change in
the large intradiscal loop D2 between the third and fourth trans-
membrane domains of the PRPH2 protein. The site is highly con-
served and mutation is predicted as probably damaging by
Polyphen.
Different retinal phenotypes have been associated with PRPH2
gene, depending on the site ofmutation. AdRPwas found to be asso-
ciated with 34 different mutations, mostly located in the D2 loop
(Boon et al., 2008) relatively early age at onset, between the 1st
and 3rd decade, has been associated with Asp173Val, Asn244Lys
and deletion of codon 118 or 119, while patients with other muta-
tions usually have onset in the 3rd–5th decade. In most cases, a de-
crease inVAdoes not occur before 50 years of age (Boon et al., 2008).
Renner et al. published phenotype data of mother and daughter
with p.Leu126Pro mutation, which is 4 amino acids upstream from
ourmutation.Mother (33 years) had normal VA on the right eye and
0.6 on the left eye while daughter (13 years) had normal VA. Both
had normal color vision (Renner et al., 2009). All our patients had
normal VA and only father (71 years, 41 years since onset) hadmod-
erately reduced color vision. Subjective disease onset varied from15
Fig. 5. Comparison of OCT in PRPH2 and USH1 patients with hyperautoﬂuorescent rings of similar size. Black lines represent points of ISe and ELM loss. White lines represent
OCT scan location. PRPH2 and USH1 patients have similar morphological stages of disease progression in macula. Both presented with hyperautoﬂuorescent rings, correlating
with photoreceptor loss on OCT. ISe line is lost ﬁrst, followed by loss of ELM line and concurrent thinning of outer nuclear layer.
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in PRPH2 phenotypes described above.
Two brothers in the studied family presented with concurrent
severe hearing loss, thus mimicking the phenotype of USH1. We
were interested if retinal phenotype could differentiate between
PRPH2 and USH1 patients. We compared phenotype of the four
PRPH2 patients with 17 USH1 patients. Twelve were so far genet-
ically analyzed and thus conﬁrmed. As they all presented with
recessive RP and congenital profound sensorineural hearing loss
it is very likely that most of them indeed have Usher syndrome.
Milder disease was described in adRP (RHO) than recessive RP
(USH2A) (Sandberg et al., 2008). Results of our study agree with
these ﬁndings. Average onset of nyctalopia was later in PRPH2
and disease progression was slower. Fundus autoﬂuorescence
and optical coherence tomography showed similar morphological
changes. Hyperautoﬂuorescent rings were seen in all PRPH2 pa-
tients and most USH1 patients in early stages while OCT showed
loss of ISe and ELM with concurrent thinning of ONL from fovea to-
wards periphery. Differentiation between retinal phenotypes of
PRPH2 and USH1 patients could only be made in the oldest PRPH2
patient (father), who retained good central visual function after
more than three decades of disease in contrast to USH1 patients
that in late stages showed severe loss of central visual function
accompanied with central FAF pattern of patch or atrophy.
This study shows that two concurrent diseases can mimic Usher
syndrome. In our case, isolated RP in father and daughter helped
with diagnosis. However in a case where parent’s data was not
known or RP was recessive or sporadic, we would not be able to
differentiate the phenotypes in the younger patients. Such combi-
nation presents a rare but possible differential diagnosis of Usher
syndrome.
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